FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3042830230> ?p ?o ?g. }

• W3042830230 endingPage "683" @default.
• W3042830230 startingPage "675" @default.
• W3042830230 abstract "Introduction Primary membranous nephropathy (PMN) is associated with the anti-phospholipase A2 receptor (anti-PLA2R) antibody in 70% of cases. Some anti-PLA2R-negative patients have the PLA2R antigen in renal tissue. This study examined the prognosis of patients with PMN according to their serum anti-PLA2R antibody (SAb) and glomerular PLA2R antigen (GAg) status.Methods Patients diagnosed with PMN were included retrospectively. Patients were grouped according to their PLA2R status into the SAb−/GAg−, SAb−/GAg+, and SAb+/GAg + groups. Baseline data, renal biopsy results, treatment, and clinical data were compared among the groups. Cox univariable and multivariable analyses examined the factors related to complete remission (CR).Results A total of 114 patients were enrolled; 10 (9%) in the SAb−/GAg−, 23 (20%) in the SAb−/GAg+, and 81 (71%) in the SAb+/GAg+ groups. Cumulative CR rate showed a significant difference between the SAb−/GAg − and SAb+/GAg+ groups (log-rank p = 0.003). The multivariable Cox proportional hazard analysis showed that age (HR = 0.968; 95%CI = 0.946–0.990; p = 0.005), SAb+/GAg+ versus SAb−/GAg− (HR = 0.387; 95%CI = 0.190–0.788; p = 0.009), SAb−/GAg+ versus SAb−/GAg− (HR = 0.398; 95%CI = 0.169, 0.939; p = 0.035), total renal chronicity score ≥2 (HR = 0.461, 95%CI: 0.277–0.766, p = 0.003), and IgA deposition (HR = 2.596; 95%CI = 1.227–5.492; p = 0.013) were all independently related (p < 0.05) to CR.Conclusions The SAb and GAg status was an indicator of PMN prognosis. The patients with SAb−/GAg − had an increased likelihood of achieving CR than those with SAb−/GAg+ and SAb+/GAg+." @default.
• W3042830230 created "2020-07-23" @default.
• W3042830230 creator A5005011099 @default.
• W3042830230 creator A5012764240 @default.
• W3042830230 creator A5018999020 @default.
• W3042830230 creator A5020084337 @default.
• W3042830230 creator A5020389679 @default.
• W3042830230 creator A5023132422 @default.
• W3042830230 creator A5035251754 @default.
• W3042830230 creator A5037178537 @default.
• W3042830230 creator A5038174266 @default.
• W3042830230 creator A5046507883 @default.
• W3042830230 creator A5054600640 @default.
• W3042830230 creator A5070350701 @default.
• W3042830230 creator A5073779383 @default.
• W3042830230 date "2020-01-01" @default.
• W3042830230 modified "2023-10-14" @default.
• W3042830230 title "Outcomes of primary membranous nephropathy based on serum anti-phospholipase A2 receptor antibodies and glomerular phospholipase A2 receptor antigen status: a retrospective cohort study" @default.
• W3042830230 cites W1124361926 @default.
• W3042830230 cites W1965172991 @default.
• W3042830230 cites W1989330059 @default.
• W3042830230 cites W1998937262 @default.
• W3042830230 cites W2083760961 @default.
• W3042830230 cites W2096722754 @default.
• W3042830230 cites W2112378652 @default.
• W3042830230 cites W2125503275 @default.
• W3042830230 cites W2131516683 @default.
• W3042830230 cites W2133344401 @default.
• W3042830230 cites W2158479143 @default.
• W3042830230 cites W2166822765 @default.
• W3042830230 cites W2191692063 @default.
• W3042830230 cites W2253333098 @default.
• W3042830230 cites W2266942539 @default.
• W3042830230 cites W2300280250 @default.
• W3042830230 cites W2333215897 @default.
• W3042830230 cites W2335807041 @default.
• W3042830230 cites W2395598045 @default.
• W3042830230 cites W2473821607 @default.
• W3042830230 cites W2494290614 @default.
• W3042830230 cites W2532400747 @default.
• W3042830230 cites W2593358114 @default.
• W3042830230 cites W2598461075 @default.
• W3042830230 cites W2606616565 @default.
• W3042830230 cites W2617482626 @default.
• W3042830230 cites W2702684557 @default.
• W3042830230 cites W2756348095 @default.
• W3042830230 cites W2775365865 @default.
• W3042830230 cites W2883290746 @default.
• W3042830230 cites W2889948708 @default.
• W3042830230 cites W2900757495 @default.
• W3042830230 cites W2904381167 @default.
• W3042830230 cites W2909780514 @default.
• W3042830230 doi "https://doi.org/10.1080/0886022x.2020.1792315" @default.
• W3042830230 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7470143" @default.
• W3042830230 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32674643" @default.
• W3042830230 hasPublicationYear "2020" @default.
• W3042830230 type Work @default.
• W3042830230 sameAs 3042830230 @default.
• W3042830230 citedByCount "8" @default.
• W3042830230 countsByYear W30428302302021 @default.
• W3042830230 countsByYear W30428302302022 @default.
• W3042830230 countsByYear W30428302302023 @default.
• W3042830230 crossrefType "journal-article" @default.
• W3042830230 hasAuthorship W3042830230A5005011099 @default.
• W3042830230 hasAuthorship W3042830230A5012764240 @default.
• W3042830230 hasAuthorship W3042830230A5018999020 @default.
• W3042830230 hasAuthorship W3042830230A5020084337 @default.
• W3042830230 hasAuthorship W3042830230A5020389679 @default.
• W3042830230 hasAuthorship W3042830230A5023132422 @default.
• W3042830230 hasAuthorship W3042830230A5035251754 @default.
• W3042830230 hasAuthorship W3042830230A5037178537 @default.
• W3042830230 hasAuthorship W3042830230A5038174266 @default.
• W3042830230 hasAuthorship W3042830230A5046507883 @default.
• W3042830230 hasAuthorship W3042830230A5054600640 @default.
• W3042830230 hasAuthorship W3042830230A5070350701 @default.
• W3042830230 hasAuthorship W3042830230A5073779383 @default.
• W3042830230 hasBestOaLocation W30428302301 @default.
• W3042830230 hasConcept C126322002 @default.
• W3042830230 hasConcept C147483822 @default.
• W3042830230 hasConcept C159641895 @default.
• W3042830230 hasConcept C159654299 @default.
• W3042830230 hasConcept C167135981 @default.
• W3042830230 hasConcept C203014093 @default.
• W3042830230 hasConcept C207103383 @default.
• W3042830230 hasConcept C2775946357 @default.
• W3042830230 hasConcept C2780091579 @default.
• W3042830230 hasConcept C2780368995 @default.
• W3042830230 hasConcept C44249647 @default.
• W3042830230 hasConcept C50382708 @default.
• W3042830230 hasConcept C71924100 @default.
• W3042830230 hasConcept C90924648 @default.
• W3042830230 hasConceptScore W3042830230C126322002 @default.
• W3042830230 hasConceptScore W3042830230C147483822 @default.
• W3042830230 hasConceptScore W3042830230C159641895 @default.
• W3042830230 hasConceptScore W3042830230C159654299 @default.
• W3042830230 hasConceptScore W3042830230C167135981 @default.
• W3042830230 hasConceptScore W3042830230C203014093 @default.
• W3042830230 hasConceptScore W3042830230C207103383 @default.

• next